Shinva Medical Instrument Co., Ltd.

Shanghai Stock Exchange 600587.SS

Shinva Medical Instrument Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 145.09 M

Shinva Medical Instrument Co., Ltd. Operating Cash Flow is USD 145.09 M for the year ending December 31, 2023, a 158.02% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Shinva Medical Instrument Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 56.23 M, a -74.52% change year over year.
Shinva Medical Instrument Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 220.73 M, a 31.21% change year over year.
Shinva Medical Instrument Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 168.23 M, a 85.69% change year over year.
Shinva Medical Instrument Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 90.60 M, a -4.61% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 600587.SS

Shinva Medical Instrument Co., Ltd.

CEO	Mr. Baoxian Gong
IPO Date	Sept. 27, 2002
Location	China
Headquarters	No. 7 Taimei Road
Employees	8,209
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers CSSD integrated solutions, pharmaceutical equipment integrated solutions, radiotherapy integrated solutions, digital operating room integrated solutions, dental integrated solutions, medical environmental protection integrated solutions, experiment animal safeguard integrated solutions, in vitro diagnostic reagents and instruments, and biomedical materials and supplies. The company also provides pharmaceutical machinery and air purifiers. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is headquartered in Zibo, the People's Republic of China.

Key trends

Past 5 years